Last updated: April 18, 2023
Sponsor: Instituto do Cancer do Estado de São Paulo
Overall Status: Active - Recruiting
Phase
N/A
Condition
Bladder Cancer
Urothelial Carcinoma
Urothelial Cancer
Treatment
N/AClinical Study ID
NCT05833997
NP1537/2019
Ages 18-80 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Patients aged between 18 and 80 years old;
- Presence of bladder tumor > 3cm without signals of MIBC or advanced disease (US, CTscan or MRI 3 months before surgery)
- Able to understand and willing to sign a written informed consent document
- Satisfactory clinical pre operatory conditions for surgery with regional or generalanesthesia.
Exclusion
Exclusion Criteria:
- Previous diagnosis of muscle-invasive bladder cancer;
- Tumor's Invasive aspect (T2 or more) on image (US, TC or RNM);
- Previous TURBT in the last 5 years;
- Urethral stenosis;
- Previous intra-vesical os systemic chemotherapy or radiotherapy;
- Previous treatment with intravesical BCG
- No clinical conditions for regional or general anesthesia;
- Any other significant disease or disorder which, in the opinion of the investigatormay either put the participant at risk because of trial participation or may influencethe trial result, or the participant's ability ti participate in the trial.
Study Design
Total Participants: 100
Study Start date:
December 10, 2020
Estimated Completion Date:
December 31, 2025
Study Description
Connect with a study center
Instituto do Cancer do Estado de São Paulo (ICESP)
São Paulo,
BrazilActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.